Senior insider sale
Chief Scientific Officer at ATRICURE, INC. — senior position signals high conviction
$374.0K
11K shares
What this filing means
DORAISWAMY VINAYAK plans to sell 11K shares of ATRICURE, INC. valued at approximately $374.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/28/2026ACC: 0001950047-26-007345
Officer· Chief Scientific Officer
Since May 2021
11K
Shares to sell
$374.0K
Approx. market value
6K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Performance Shares
Not Applicable
3/1/2025
3.40KPerformance Shares
Not Applicable
3/1/2023
2.60KTotal acquired6K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2025 | Performance Shares Not Applicable | 3.40K | — |
3/1/2023 | Performance Shares Not Applicable | 2.60K | — |
| Total | 6K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5K
Market value
$140.7K
5/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
6K
Market value
$233.3K
7/28/2026
Total
Units
11K
Value
$374.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/15/2026 | 5K | $140.7K | — | Completed |
| Planned — Approximate Date | ||||
7/28/2026 | 6K | $233.3K | NASDAQ | Planned |
| Total | 11K | $374.0K | ||